Lechien Jerome R
Polyclinic of Poitiers, Elsan Hospital, 86000 Poitiers, France.
Department of Anatomy and Experimental Oncology, Mons School of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), 7000 Mons, Belgium.
J Clin Med. 2022 Jun 1;11(11):3158. doi: 10.3390/jcm11113158.
Purpose: The diagnosis of laryngopharyngeal reflux (LPR) is commonly based on non-specific symptoms and findings and a positive response to an empirical therapeutic trial. The therapeutic response is, however, unpredictable, and many patients need pH-impedance monitoring to confirm the diagnosis. Methods: A review of the recent literature was conducted in PubMED, Scopus, and Embase about the pH-study features of LPR patients. A summary of last evidence was proposed. Results: The awareness of otolaryngologists about indications and interpretation of pH-impedance monitoring is low. The hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring (HEMII-pH) is the most reliable examination determining the type and composition of hypopharyngeal reflux events (HRE) and the LPR features. The use of HEMII-pH is important to confirm the diagnosis in selected patients because non-specificity of symptoms and findings. There are no international consensus guidelines for the LPR diagnosis at the HEMII-pH. However, most studies supported the occurrence of >1 acid/weakly acid/nonacid HRE as diagnostic threshold. HREs are more frequently gaseous, weakly/nonacid compared with reflux events of gastroesophageal reflux. HREs occurred as daytime and upright, which does not support the value of double proton pump inhibitors or bedtime alginate. Oropharyngeal pH-monitoring is another approach reporting different sensitivity and specificity outcomes from HEMII-pH. The use of Ryan score for the LPR diagnosis at the oropharyngeal pH monitoring may be controversial regarding the low consideration of alkaline HREs. Conclusions: The awareness of otolaryngologists about HEMII-pH indication, features, and interpretation is an important issue regarding the high prevalence of LPR in outpatients consulting in otolaryngology. The HEMII-pH findings may indicate a more personalized treatment considering type and occurrence time of HREs.
喉咽反流(LPR)的诊断通常基于非特异性症状和体征以及经验性治疗试验的阳性反应。然而,治疗反应是不可预测的,许多患者需要进行pH阻抗监测以确诊。方法:在PubMed、Scopus和Embase上对近期关于LPR患者pH研究特征的文献进行综述,并提出最新证据总结。结果:耳鼻喉科医生对pH阻抗监测的适应证和解读的认识较低。下咽-食管多通道腔内阻抗-pH监测(HEMII-pH)是确定下咽反流事件(HRE)类型和组成以及LPR特征的最可靠检查。由于症状和体征的非特异性,使用HEMII-pH对选定患者进行诊断确认很重要。目前尚无关于HEMII-pH诊断LPR的国际共识指南。然而,大多数研究支持将>1次酸/弱酸/非酸HRE的发生作为诊断阈值。与胃食管反流事件相比,HRE更多为气态、弱酸/非酸。HRE发生在白天和直立位,这不支持双倍质子泵抑制剂或睡前使用藻酸盐的价值。口咽pH监测是另一种方法,其报告的敏感性和特异性结果与HEMII-pH不同。在口咽pH监测中使用Ryan评分诊断LPR可能存在争议,因为对碱性HRE的考虑较少。结论:对于在耳鼻喉科门诊就诊的LPR高患病率患者,耳鼻喉科医生对HEMII-pH适应证、特征和解读的认识是一个重要问题。HEMII-pH的结果可能表明应根据HRE的类型和发生时间进行更个性化的治疗。